← Leaderboards
Thomas Eling
Environmental Health Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Environmental Health Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisEnzyme ActivityProstaglandinsLipoxygenaseGene ExpressionChemopreventionTissue /Cell CultureCell ProliferationBreastAngiogenesisMalignant NeoplasmsColonLipidsInflammationAspirinHuman TissueEnzymesLinoleic AcidsEventColon CarcinomaBiologicalColorectal CancerBiochemical ProcessBiochemical
Grant awards (34)
Anti-carcinogenic Activity Of Cox inhibitors and NAG-1$972,039
ZIA · FY2013 · ES · contact PI
Anti-carcinogenic Activity Of Cox inhibitors and NAG-1$1,185,009
ZIA · FY2012 · ES · contact PI
Role Of Lipids In Colon, Breast, And Other Cancers$215,456
ZIA · FY2012 · ES · contact PI
Anti-carcinogenic Activity Of Cox inhibitors and NAG-1$1,610,260
ZIA · FY2011 · ES · contact PI
Role Of Lipids In Colon, Breast, And Other Cancers$602,723
ZIA · FY2011 · ES · contact PI
Anti-carcinogenic Activity Of Cox inhibitors and NAG-1$2,350,834
ZIA · FY2010 · ES · contact PI
Role Of Lipids In Colon, Breast, And Other Cancers$547,454
ZIA · FY2010 · ES · contact PI
Anti-carcinogenic Activity Of Cox inhibitors and NAG-1$2,172,019
ZIA · FY2009 · ES · contact PI
Role Of Lipids In Colon, Breast, And Other Cancers$467,820
ZIA · FY2009 · ES · contact PI
Anti-carcinogenic Activity Of Cox inhibitors and NAG-1$1,348,547
Z01 · FY2008 · ES · contact PI
Role Of Lipids In Colon, Breast, And Other Cancers$380,285
Z01 · FY2008 · ES · contact PI
Anti-carcinogenic Activity Of Cox inhibitors and NAG-1$1,433,826
Z01 · FY2007 · ES · contact PI
Role Of Lipids In Colon, Breast, And Other Cancers$457,604
Z01 · FY2007 · ES · contact PI
Role Of Lipids In Colon, Breast, And Other Cancers$0
Z01 · FY2006 · ES · contact PI
Anti-carcinogenic Activity Of Cox inhibitors and NAG-1$0
Z01 · FY2006 · ES · contact PI
Anti-carcinogenic Activity--Nsaids Mediated By New Tgf-b$0
Z01 · FY2005 · ES
Role Of Lipids In Colon, Breast, and other Cancers$0
Z01 · FY2005 · ES
Role Of Lipids In Colon, Prostate, And Other Cancers$0
Z01 · FY2004 · ES
Interaction of Signaling Pathways with Lipid Metabolites$0
Z01 · FY2004 · ES
Mediation of Anti-carcinogenic Activity Of NSAIDS$0
Z01 · FY2004 · ES
Anti-carcinogenic Activity Of Nsaids Mediated By A New T$0
Z01 · FY2003 · ES
Role Of Lipids In Colon, Breast, And Other Cancers$0
Z01 · FY2003 · ES
Interaction Of Signaling Pathways With Lipid Metabolites$0
Z01 · FY2003 · ES
Interaction Of Signaling Pathways With Lipid Metabolites$0
Z01 · FY2002 · ES
Role Of Lipids In Colon, Breast, And Other Cancers$0
Z01 · FY2002 · ES
Anti-carcinogenic Activity Of Nsaids Mediated By A New T$0
Z01 · FY2002 · ES
Anticarcinogenic Activity Of NSAID Mediated By TGFB GENE$0
Z01 · FY2001 · ES
Role of Lipids in Colon, Breast, and other Cancers$0
Z01 · FY2001 · ES
Interaction of signaling pathways with lipid metabolites$0
Z01 · FY2001 · ES
Mechanism Of Carcinogens-Genetic Alterations In Rodent$0
Z01 · FY2001 · ES
Anti-carcinogenic activity of NSAIDs mediated by a new TGF-Beta superfamily gene$0
Z01 · FY2000 · ES
MECHANISMS THAT REGULATE ENZYMES THAT METABOLIZE CIS UNSATURATED FATTY ACIDS$0
Z01 · FY2000 · ES
ROLE OF LIPIDS IN COLON CANCER$0
Z01 · FY2000 · ES
INTERACTION OF LIPIDS WITH EGFR SIGNALING PATHWAY$0
Z01 · FY2000 · ES